1. Clinical responses to therapy from baseline to week 24 and end point with last observation carried forward (LOCF).
Clinical responses to therapy from baseline to week 24 and end point with last observation carried forward (LOCF). A: Mean HbA1c (%) by visit. B: Mean fasting plasma glucose (mmol/L) by visit. C: Mean change in body weight (kg) from baseline by visit. D:Mean daily basal insulin dose (units/day) by visit. Values are mean ± SE. The end point with LOCF calculation used the modified intention-to-treat population. All analyses excluded measurements after the introduction of rescue medication or after treatment cessation plus 14 days, or both.
Matthew C. Riddle et al. Dia Care 2013;36:
©2013 by American Diabetes Association